Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Aetna profit beats as government plans expand

Published 08/04/2015, 07:18 AM
Updated 08/04/2015, 07:26 AM
© Reuters. A trader points up at a display on the floor of the New York Stock Exchange

(Reuters) - Aetna Inc (N:AET) reported a better-than-expected adjusted net profit for the second quarter as it added more members to its government plans and medical costs remained stable.

The third-largest U.S. health insurer, which is in the process of buying rival Humana Inc (N:HUM), also raised its full-year forecast for adjusted net profit to at least $7.40 per share from $7.20-$7.40.

Memberships in government-sponsored plans have increased as Obamacare has expanded health insurance coverage to thousands of uninsured and under-insured U.S. citizens.

Aetna said on Tuesday it continued to experience moderate medical cost trends during the quarter, which helped improve its medical benefit ratio to 81.1 percent from 83.1 percent.

The ratio, the percentage of premium income that an insurer spends on medical claims, is tracked by investors for signs of any increase in medical spending.

Medical costs are expected to rise as the economy improves and the rate of overall health spending increases, driving insurers to consolidate.

Aetna agreed to buy Humana in early July for $37 billion, just weeks before Anthem Inc (N:ANTM) and Cigna Corp (N:CI) reached a deal for $47 billion.

Aetna's net profit rose to $731.8 million, or $2.08 per share, in the second quarter ended June 30, from $548.8 million, or $1.52 per share, a year earlier.

Excluding items, the company earned $2.05 per share, beating average analyst estimate of $1.82 per share, according to Thomson Reuters I/B/E/S.

Revenue rose 5 percent to $15.24 billion, still short of analyst expectations of $15.43 billion.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.